PCCA recognized excellence in pharmacy compounding with the presentation of two annual awards during CONNEXT: Canadian Compounding Conference 2026, today in Edmonton, Alberta. The awards celebrate ...

Could perimenopause be the reason you're not performing like you used to at work? Absolutely, says pharmacist Dr. Brandy ...

Aqtual, Inc., a precision medicine company developing active chromatin cell-free DNA (cfDNA) diagnostics for oncology and chronic disease, today announced new findings demonstrating its blood-based ...

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth ...

Vijay Martis analyses the growing “automation premium” in healthcare, where AI deployment can cost more than the clinicians it is intended to supplement.

Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...

Cosmos Health Inc. ("Cosmos Health" or the "Company") , a diversified, vertically integrated global healthcare group, today announced its financial guidance for the 2026?2029 period. Cosmos Health ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...

PCCA today announced the launch of ExoBlue™, a sophisticated cosmetic topical base developed to meet the growing demand for more integrated, personalized skincare solutions. This new base offers ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US regulator ...

Market Decipher has released the India Protein Market Report, 2026-2036 - a rigorous intelligence study purpose-built for senior decision-makers navigating ...